San Diego Biotech Networks

From AGBT: Early Bird Rates End August 3: Save Over $200 for AGBT Precision Health https://conta.cc/3Tt6oEn Join world-renowned leaders in precision medicine, genomics, AI, and rare disease this September in San Diego, California. Register by August 3 and Save Over $200 Connect with leading scientists, clinicians, biotechnology innovators, and healthcare leaders advancing precision medicine at the 2026 AGBT Precision Health Meeting, September 14–16 in San Diego, California. Explore the latest advances in AI, genomics, precision therapeutics, rare disease, and diagnostics while building valuable collaborations across academia, healthcare, and industry. Register Today: https://lnkd.in/ew9Bu-5a Why Attend AGBT Precision Health? ✅ Learn from world-renowned leaders in genomic medicine. ✅ Discover emerging technologies and clinical applications. ✅ Build collaborations and business opportunities. ✅ Experience AGBT's unique single-track program designed for meaningful scientific discussions and networking. ✅ Present your latest research with leaders across genomics and healthcare. Early Bird Registration Rates End August 3 Register today and save over $200. Complete a short form on the link below to receive an additional $100 discount and gain access to the 2025 AGBT Precision Health Meeting Book. Get Extra $100 Off: https://lnkd.in/ew9Bu-5a Meet Some of Our Featured Speakers Niall Lennon Director of Genomics, Broad Institute of MIT & Harvard and Chief Scientific Officer, Broad Clinical Labs. GUINNESS WORLD RECORDS™ recipient for fastest DNA sequencing technique. Alexis Battle Professor, Johns Hopkins University and pioneer in applying AI and machine learning to genomic and health data. Kiran Musunuru Cardiologist and Professor, Perelman School of Medicine at the University of Pennsylvania. He was named one of TIME's 100 Most Influential People of 2026. View the Full Agenda: https://lnkd.in/g4a2pdNz Supported by Industry Leaders Join leading organizations including GeneDx, Nabsys, SeqOne, Illumina, Omega Bio-Tek, AstraZeneca, and Invivoscribe, Inc. "This conference is the right people doing the right things and discussing the right topics. They stay current and bring together a highly relevant audience." — Sponsor of Precision Health 2025 Become a Sponsor or Exhibitor: https://lnkd.in/e68AWvuX

SDBN Feed: Landmark Bio and Syngoi Technologies to Operate as Artis BioSolutions, an End-to-end Gene-to-GMP Platform for Genetic Medicines https://lnkd.in/g-VaycdH SAN DIEGO–(BUSINESS WIRE)– #ArtisBioSolutions–Artis BioSolutions, an advanced therapies company built to streamline the discovery, development, and production of genetic medicines, today announced that both Landmark Bio, its Watertown, Massachusetts-based development and GMP manufacturing operation, and Syngoi, its Bilbao, Spain-based enzymatic synthetic DNA business, will now operate under the Artis BioSolutions name. The change unifies Artis’ U.S. and European capabilities under a single brand, completing a tr Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

SDBN Feed: Ionis announces Dr. Frank Bennett, chief scientific officer, to retire https://lnkd.in/gg_zSgvt CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that Frank Bennett, Ph.D., executive vice president and chief scientific officer, will retire effective February 2027.“As a founding scientist, Frank has been instrumental in shaping Ionis and advancing the entire field of RNA-targeted medicines,” said Brett P. Monia, Ph.D., chief executive officer, Ionis. “Frank’s profound contributions include pioneering the use of antisense medicines in neurological Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

SDBN Feed: Spinal Elements Launches Luna® Ti https://lnkd.in/g7D5Q3pY Bringing Novel Titanium Integrated Surface Technology to the Proven Platform CARLSBAD, Calif., July 29, 2026 /PRNewswire/ — Spinal Elements®, a spine technology company known for developing innovative surgical solutions that prioritize clinical performance and surgical efficiency, today… Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

SDBN Feed: UC San Diego Team Awarded $50K to Explore Connections Between Art and Neuroscience https://lnkd.in/guyPP_Gy Does experiencing art have the capacity to quiet an overactive mind and inspire a state of awe? An audio artist, neuroscientist and visual designer at UC San Diego have teamed up to find out. Their unique project received $50K in private support from the Bobby Anspach Studios Foundation. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

SDBN Feed: From Code to Care: How UC San Diego Is Leading the Way in AI for Health Care https://lnkd.in/gEKd36p6 At the U.S. News & World Report Healthcare of Tomorrow conference, leaders from UC San Diego and from across the health care industry gathered in Washington, D.C., to explore a defining question: How can artificial intelligence improve health care while keeping patients at the center? Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

SDBN Feed: Travere Therapeutics to Report Second Quarter 2026 Financial Results https://lnkd.in/gH-cT2zC SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere’s website at https://lnkd.in/gZHYK58r. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

SDBN Feed: Curebound Strengthens Leadership with Three Key Executive Hires https://lnkd.in/g_S9tYdx SAN DIEGO–(BUSINESS WIRE)– #CancerChallenge–Curebound announced three key additions to its leadership team. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks

We are a week away from our Summer BBQ with Vertex Pharmaceuticals! RVSP soon as we will sell out! https://lnkd.in/emKreS6b Come join the fun at this outdoors event at the beautiful San Diego Vertex Campus and meet other life science professionals in the community. Hope to see you there!

SDBN Feed: CG Life Combines With AI-Native Agency The Considered+AI to Create a New Model of Commercialization Partner https://lnkd.in/gyusZUCz CHICAGO & NEW YORK & SAN DIEGO–(BUSINESS WIRE)–CG Life, a specialized pharma agency built for the unique challenges of bringing therapies for rare, specialty, and hard-to-treat diseases to market, has combined with The Considered+AI, an AI-native agency built from inception for the era of generative AI. The union blends CG Life’s rare disease and precision medicine expertise with The Considered’s proven approach to amplifying world-class talent through AI to commercialize therapies with great Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks